CVS Health Corporation (CVS) is scheduled to report third-quarter 2024 results on Nov. 6, before the opening bell.In the last reported quarter, the company’s adjusted earnings of $1.83 exceeded the Zacks Consensus Estimate by 5.17%. CVS Health beat estimates in three of the trailing four quarters and missed in one, the average positive surprise being 2.02%.The Zacks Consensus Estimate for third-quarter revenues is pegged at $92.87 billion, suggesting growth of 3.5% year over year. The consensus estimate for ...